LEONARD JOHN M
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to LEONARD JOHN M. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NTLA | President and CEO | Sale | 49,959 | $9.49 | $474,111 | Dec 11, 2025 |
| IQV | Award / Grant | 1,592 | — | — | Apr 24, 2025 | |
| NTLA | President and CEO | Award / Grant | 136,000 | — | — | Mar 1, 2025 |
| NTLA | President and CEO | Sale | 26,807 | $12.18 | $326,509 | Jan 3, 2025 |
| NTLA | President and CEO | Option Exercise | 7,850 | — | — | Jan 1, 2025 |
| IQV | Award / Grant | 1,047 | — | — | May 7, 2024 | |
| NTLA | President and CEO | Award / Grant | 113,586 | — | — | Mar 1, 2024 |
| NTLA | President and CEO | Sale | 19,223 | $29.46 | $566,310 | Jan 3, 2024 |
| NTLA | President and CEO | Option Exercise | 7,848 | — | — | Jan 1, 2024 |
| IQV | Award / Grant | 1,063 | — | — | May 10, 2023 | |
| NTLA | President and CEO | Award / Grant | 91,036 | — | — | Mar 1, 2023 |
| NTLA | President and CEO | Sale | 6,673 | $37.21 | $248,302 | Jan 4, 2023 |
| NTLA | President and CEO | Option Exercise | 7,848 | — | — | Jan 1, 2023 |
| IQV | Award / Grant | 995 | — | — | May 11, 2022 | |
| NTLA | President and CEO | Sale | 2,493 | $112.26 | $279,864 | Jan 1, 2022 |
| NTLA | President and CEO | Option Exercise | 27,167 | $14.58 | $396,095 | Aug 30, 2021 |
| NTLA | President and CEO | Sale | 18,874 | $151.54 | $2,860,166 | Aug 23, 2021 |
| NTLA | President and CEO | Option Exercise | 22,682 | $13.40 | $303,939 | Aug 19, 2021 |
| IQV | Award / Grant | 934 | — | — | Apr 15, 2021 | |
| NTLA | President and CEO | Option Exercise | 10,000 | $6.83 | $68,300 | Apr 13, 2021 |
| NTLA | President and CEO | Option Exercise | 45,000 | $14.58 | $656,100 | Apr 1, 2021 |
| NTLA | President and CEO | Option Exercise | 56,718 | $6.83 | $387,384 | Feb 5, 2021 |
| NTLA | President and CEO | Sale | 3,497 | $64.16 | $224,368 | Feb 1, 2021 |
| NTLA | President and CEO | Sale | 6,239 | $55.86 | $348,511 | Dec 31, 2020 |
| NTLA | President and CEO | Option Exercise | 20,000 | $14.58 | $291,600 | Nov 27, 2020 |
| NTLA | President and CEO | Option Exercise | 50,000 | $6.83 | $341,500 | Nov 25, 2020 |
| NTLA | President and CEO | Option Exercise | 20,000 | $14.58 | $291,600 | Nov 16, 2020 |
| NTLA | President and CEO | Sale | 50,000 | $26.00 | $1,300,000 | Nov 4, 2020 |
| NTLA | President and CEO | Sale | 5,000 | $21.83 | $109,150 | Oct 7, 2020 |
| NTLA | President and CEO | Sale | 5,000 | $21.83 | $109,150 | Sep 1, 2020 |
| NTLA | President and CEO | Option Exercise | 5,000 | $6.83 | $34,150 | Aug 6, 2020 |
| NTLA | President and CEO | Option Exercise | 5,000 | $6.83 | $34,150 | Jul 1, 2020 |
| NTLA | President and CEO | Sale | 5,000 | $21.83 | $109,150 | Jun 3, 2020 |
| IQV | Award / Grant | 1,492 | — | — | May 6, 2020 | |
| IQV | Option Exercise | 6,600 | $64.93 | $428,538 | Dec 20, 2019 | |
| IQV | Award / Grant | 1,478 | — | — | May 16, 2019 | |
| NTLA | President and CEO | Sale | 8,400 | $24.00 | $201,600 | May 14, 2018 |
| IQV | Award / Grant | 2,072 | — | — | Apr 26, 2018 | |
| NTLA | EVP, R&D | Award / Grant | 600 | $12.09 | $7,254 | Jun 1, 2017 |
| IQV | Award / Grant | 2,386 | — | — | May 23, 2017 | |
| 0001117480 | Sale | 5,000 | $5.03 | $25,150 | Sep 15, 2016 | |
| IQV | Award / Grant | 775 | — | — | May 5, 2016 | |
| 0001117480 | Purchase | 1,000 | $47.38 | $47,380 | Aug 21, 2015 | |
| IQV | Award / Grant | 771 | — | — | May 7, 2015 | |
| IQV | Award / Grant | 770 | — | — | Mar 4, 2015 | |
| 0001117480 | Purchase | 4,000 | $29.00 | $116,000 | Nov 5, 2014 | |
| ABBV | SVP, Chief Scientific Officer | Sale | 46,700 | $38.45 | $1,795,615 | Mar 15, 2013 |
| ABBV | SVP, Chief Scientific Officer | Sale | 23,644 | $37.50 | $886,650 | Mar 8, 2013 |
| ABBV | SVP, Chief Scientific Officer | Tax Withholding | 9,407 | $36.73 | $345,519 | Feb 28, 2013 |
| ABBV | SVP, Chief Scientific Officer | Tax Withholding | 25,345 | $37.58 | $952,465 | Feb 19, 2013 |